Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids - PubMed (original) (raw)
Comparative Study
Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids
N C Lan et al. J Clin Endocrinol Metab. 1982 Feb.
No abstract available
Similar articles
- Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
Beaumont K, Fanestil DD. Beaumont K, et al. Endocrinology. 1983 Dec;113(6):2043-51. doi: 10.1210/endo-113-6-2043. Endocrinology. 1983. PMID: 6227474 - RU-26988--a new tool for the study of the mineralocorticoid receptor.
Gomez-Sanchez CE, Gomez-Sanchez EP. Gomez-Sanchez CE, et al. Endocrinology. 1983 Sep;113(3):1004-9. doi: 10.1210/endo-113-3-1004. Endocrinology. 1983. PMID: 6307658 - Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
Baker ME, Funder JW, Kattoula SR. Baker ME, et al. J Steroid Biochem Mol Biol. 2013 Sep;137:57-70. doi: 10.1016/j.jsbmb.2013.07.009. Epub 2013 Jul 29. J Steroid Biochem Mol Biol. 2013. PMID: 23907018 Review. - Studies on high affinity binding of mineralo- and glucocorticoids in rabbit aorta cytosol.
Kornel L, Kanamarlapudi N, Travers T, Taff DJ, Patel N, Chen C, Baum RM, Raynor WJ. Kornel L, et al. J Steroid Biochem. 1982 Feb;16(2):245-64. doi: 10.1016/0022-4731(82)90173-x. J Steroid Biochem. 1982. PMID: 6281578 Review.
Cited by
- Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues.
Zola M, Mejlachowicz D, Gregorio R, Naud MC, Jaisser F, Zhao M, Behar-Cohen F. Zola M, et al. Int J Mol Sci. 2022 Jan 24;23(3):1278. doi: 10.3390/ijms23031278. Int J Mol Sci. 2022. PMID: 35163201 Free PMC article. - Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone.
Yang Z, Ni Y, Zhao D, Zhang Y, Wang J, Jiang L, Chen D, Wu Z, Wang Y, He L, Shi Y, Zhou F, Zeng H, Li Y. Yang Z, et al. BMC Cancer. 2021 Aug 13;21(1):919. doi: 10.1186/s12885-021-08670-2. BMC Cancer. 2021. PMID: 34388965 Free PMC article. - Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
Feger M, Ewendt F, Strotmann J, Schäffler H, Kempe-Teufel D, Glosse P, Stangl GI, Föller M. Feger M, et al. J Mol Med (Berl). 2021 May;99(5):699-711. doi: 10.1007/s00109-021-02036-8. Epub 2021 Jan 30. J Mol Med (Berl). 2021. PMID: 33517471 Free PMC article. - The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism.
Choudhury S, Tan T, Lazarus K, Meeran K. Choudhury S, et al. Endocr Connect. 2021 Feb;10(2):R66-R76. doi: 10.1530/EC-20-0473. Endocr Connect. 2021. PMID: 33449916 Free PMC article. Review. - Corticosteroid switch after progression on abiraterone acetate plus prednisone.
Roviello G, Sobhani N, Corona SP, D'Angelo A. Roviello G, et al. Int J Clin Oncol. 2020 Feb;25(2):240-246. doi: 10.1007/s10147-019-01577-w. Epub 2019 Nov 8. Int J Clin Oncol. 2020. PMID: 31705219 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical